The CRISPR system is a powerful tool for the targeted editing of genomes, with significant therapeutic potential, but runs the risk of inappropriately editing ”off-target” sites. However, a new study shows that mutating the enzyme at the heart of the CRISPR gene editing system can improve its fidelity.